Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Herbert L Cantrill, MD
VitreoRetinal Surgery, PA
Principal Investigator - Robert L Avery, MD
California Retinal Consultants
Principal Investigator - Tamer H Mahmoud, MD, PhD
Kresege Eye Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Retinal Consultants of Arizona
Phoenix, Arizona, United States
- California Retina Consultants
Santa Barbara, California, United States
- Kresege Eye Institute
Detroit, Michigan, United States
- Vitreoretinal Surgery, Pa
Edina, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2005
- Primary completion
- 30 Apr 2009
- Completion
- 31 May 2009
- Last update posted
- 9 Jun 2023
- Registered enrollment
- 31
- Registry id
- NCT00915837
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.